ARK Genomic Revolution ETF
ARKG
168 hedge funds and large institutions have $483M invested in ARK Genomic Revolution ETF in 2020 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 55 increasing their positions, 14 reducing their positions, and 15 closing their positions.
600% more funds holding in top 10
Funds holding in top 10: 1 → 7 (+6)
420% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 15
293% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 14
179% more capital invested
Capital invested by funds: $173M → $483M (+$310M)
58% more funds holding
Funds holding: 106 → 168 (+62)
2.93% more ownership
Funds ownership: 33.51% → 36.44% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Mainstay Capital Management
Grand Blanc,
Michigan
|
+$16.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$15.8M |
| 3 |
Morgan Stanley
New York
|
+$14.9M |
| 4 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
+$10.1M |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$8.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Financial Engines Advisors
Santa Clara,
California
|
-$1.57M |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
-$1.26M |
| 3 |
CWM
Concentrum Wealth Management
San Jose,
California
|
-$1.23M |
| 4 |
Jane Street
New York
|
-$950K |
| 5 |
KA
Kovack Advisors
Ft. Lauderdale,
Florida
|
-$835K |
ARKG Hedge Fund Activity: Q2 2020 in Review
168 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2020, worth a combined $483M — up 179% from $173M a quarter earlier.
Buyers outnumbered sellers: 78 funds opened new ARKG positions and 15 closed out — a net gain of 63 holders — while 55 added to existing stakes and 14 trimmed.
The largest buyer was Mainstay Capital Management, adding an estimated $16.9M. The largest seller was Financial Engines Advisors, exiting entirely with an estimated $1.57M sold.
- 168 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2020, up from 106 in Q1 2020.
- Funds reported $483M of ARK Genomic Revolution ETF stock for Q2 2020, up 179% quarter-over-quarter.
- 78 funds opened new ARK Genomic Revolution ETF positions in Q2 2020 and 15 closed out, a net change of +63 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2020 was Mainstay Capital Management, an estimated $16.9M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2020 was Financial Engines Advisors, an estimated $1.57M sold.
Based on aggregated 13F filings for Q2 2020.